Latest filing published 02 Oct 2013 for IVERIC bio, Inc., €11k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas Dyrberg: trading record in brief
Thomas Dyrberg discloses dealings in 2 companies, chiefly Biomimetic Therapeutics, Inc. and IVERIC bio, Inc. In total, 6 filings cover trades dated from 11 May 2006 to 30 September 2013.
The open-market record is one-sided, with 2 purchases worth €3.2M and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2013 alone, the filings show 1 purchase and no sales.
The latest filing, published on 2 October 2013, reports an open-market purchase of €11k in IVERIC bio, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Thomas Dyrberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 700 shares@ US$22.00COMMON STOCKSEC:0001209191-13-046855:0Canonical exit: 29 Dec 2013 (T+90)
- 335,575 shares@ US$12.46Common StockSEC:0001209191-07-005540:0Canonical exit: 25 Apr 2007 (T+90)
- 343,574 shares0Common StockSEC:0001209191-06-062570:0
- 758,097 sharesCommon StockSEC:0001209191-06-030032:0
- 196,351 sharesCommon StockSEC:0001209191-06-030032:1
- 738,174 sharesCommon StockSEC:0001209191-06-030032:2
6 of 6 declarations
